40.89

0.58% -0.19

Atricure Inc (ATRC)

Overview News Price History Option Chain Financials Discussions Forecast

Atricure Inc stock is traded at $40.89, with a volume of 162.58K. It is down -0.58% in the last 24 hours and up +23.32% over the past month. AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Previous Close:

$41.08

Open:

$41.2

24h Volume:

162.58K

Relative Volume:

0.33

Market Cap:

$2.03B

Revenue:

$499.95M

Net Income/Loss:

$-36.36M

P/E Ratio:

-53.10

EPS:

-0.77

Net Cash Flow:

$24.22M

1W Performance:

-0.82%

1M Performance:

+23.32%

6M Performance:

+25.28%

1Y Performance:

+29.66%

1-Day Range:

$40.60

$41.95

1-Week Range:

$40.60

$42.60

52-Week Range:

$28.29

$43.11

Atricure Inc Stock (ATRC) Company Profile

Name

Atricure Inc

Sector

Healthcare (1131)

Industry

Medical Instruments & Supplies (57)

Phone

513-755-4100

Address

7555 INNOVATION WAY, MASON, OH

Employee

1,300

Twitter

@AtriCure

Next Earnings Date

2024-10-29

Latest SEC Filings

ATRC's Discussions on Twitter

Compare ATRC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATRC Atricure Inc	40.84	2.04B	499.95M	-36.36M	24.22M	-0.77
ISRG Intuitive Surgical Inc	555.07	196.60B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	195.57	56.05B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	79.52	38.81B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	246.50	36.10B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	269.15	19.17B	2.96B	487.70M	344.00M	6.6758

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Resumed	JP Morgan	Overweight
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-29-23	Initiated	UBS	Buy
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy
Nov-06-20	Reiterated	Needham	Buy
Apr-07-20	Initiated	Oppenheimer	Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jan-24-20	Reiterated	Needham	Buy
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform
Apr-12-19	Initiated	JP Morgan	Overweight
Oct-04-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Stifel	Buy
Jun-18-18	Reiterated	Needham	Buy
Apr-27-18	Reiterated	Needham	Buy
Jan-16-18	Reiterated	Needham	Buy
Nov-02-17	Reiterated	Needham	Buy
Jul-28-17	Reiterated	Needham	Buy
May-30-17	Resumed	Piper Jaffray	Overweight
Jun-30-16	Resumed	JMP Securities	Mkt Outperform
Oct-28-15	Reiterated	Needham	Buy
Oct-06-15	Reiterated	Canaccord Genuity	Buy
Oct-06-15	Reiterated	Needham	Buy

View All

Atricure Inc Stock (ATRC) Latest News

08:00 AM

AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference - Business Wire

08:00 AM

Dec 16, 2025

JPMorgan Chase & Co. Boosts AtriCure (NASDAQ:ATRC) Price Target to $48.00 - MarketBeat

Dec 16, 2025

AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human SuccessHas The Bull Case Changed? - Yahoo Finance

Dec 13, 2025

Dec 12, 2025

Loss Report: What valuation multiples suggest for AtriCure Inc stockJuly 2025 Outlook & Fast Entry Momentum Alerts - moha.gov.vn

Dec 12, 2025

AtriCure treats first patients with dual PFA/RF system - MedTech Dive

Dec 12, 2025

ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform - Finviz

Dec 12, 2025

Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year? - MSN

Dec 12, 2025

Dec 11, 2025

AtriCure reports first patients treated with dual-energy PFA, RF platform - MassDevice

Dec 11, 2025

AtriCure Announces the First Patients Treated with Novel Dual Energy Platform - 01net

Dec 11, 2025

AtriCure, Inc. Announces the First Patients Treated with Novel Dual Energy Platform - marketscreener.com

Dec 11, 2025

AtriCure Reports 1st Treatments with Dual Energy RF, PFA System - Medical Product Outsourcing

Dec 11, 2025

AtriCure Says First Patients Treated With Dual-Energy Platform - marketscreener.com

Dec 11, 2025

AtriCure (ATRC) Introduces Cutting-Edge Dual Energy Platform in Initial Treatments - GuruFocus

Dec 11, 2025

AtriCure, Inc.'s (NASDAQ:ATRC) 29% Share Price Surge Not Quite Adding Up - simplywall.st

Dec 11, 2025

Russell Investments Group Ltd. Decreases Stake in AtriCure, Inc. $ATRC - MarketBeat

Dec 11, 2025

AtriCure Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily

Dec 11, 2025

Dec 08, 2025

Are Medical Stocks Lagging AtriCure (ATRC) This Year? - Yahoo Finance

Dec 08, 2025

Hood River Capital Management LLC Has $100.31 Million Holdings in AtriCure, Inc. $ATRC - MarketBeat

Dec 08, 2025

Dec 05, 2025

Will AtriCure Inc. stock deliver strong dividend growthPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser

Dec 05, 2025

Dec 03, 2025

Why analysts remain bullish on AtriCure Inc. stock2025 Trading Recap & Consistent Growth Stock Picks - Newser

Dec 03, 2025

Nov 30, 2025

AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 30, 2025

Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? - AOL.com

Nov 30, 2025

Nov 28, 2025

AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance - MSN

Nov 28, 2025

Geode Capital Management LLC Purchases 14,577 Shares of AtriCure, Inc. $ATRC - MarketBeat

Nov 28, 2025

Nov 27, 2025

How supply chain issues affect AtriCure Inc. stockJuly 2025 Volume & Scalable Portfolio Growth Methods - BỘ NỘI VỤ

Nov 27, 2025

Insider Selling: AtriCure (NASDAQ:ATRC) Director Sells 4,967 Shares of Stock - MarketBeat

Nov 27, 2025

Nov 26, 2025

Atricure Executives Make Significant Stock Sales - TipRanks

Nov 26, 2025

Insider Sell: Justin Noznesky Sells 5,166 Shares of AtriCure Inc (ATRC) - GuruFocus

Nov 26, 2025

AtriCure Executives Engage in Stock Transactions - TradingView

Nov 26, 2025

Atricure Insider Sold Shares Worth $376,578, According to a Recent SEC Filing - MarketScreener

Nov 26, 2025

Dir Wehrwein Sells 10,000 ($376.6K) Of AtriCure Inc [ATRC] - TradingView

Nov 26, 2025

Officer Noznesky Sells 5,166 ($192.6K) Of AtriCure Inc [ATRC] - TradingView

Nov 26, 2025

ATRC Form 4: Director exercises $19.95 options, trims holdings - Stock Titan

Nov 26, 2025

[Form 4] AtriCure, Inc. Insider Trading Activity - Stock Titan

Nov 26, 2025

Precision Trading with Atricure Inc. (ATRC) Risk Zones - news.stocktradersdaily.com

Nov 26, 2025

Officer Noznesky Files To Sell 5,166 Of AtriCure Inc [ATRC] - TradingView

Nov 26, 2025

Atricure Director Makes a Significant Stock Sale! - TipRanks

Nov 26, 2025

AtriCure director Yuen sells $107k in shares By Investing.com - Investing.com Australia

Nov 26, 2025

Nov 25, 2025

Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade - Finviz

Nov 25, 2025

Insider Sell: Maggie Yuen Sells 3,000 Shares of AtriCure Inc (AT - GuruFocus

Nov 25, 2025

AtriCure director Yuen sells $107k in shares - Investing.com

Nov 25, 2025

AtriCure Director Maggie Yuen Sells 3,000 Shares - TradingView

Nov 25, 2025

Nov 24, 2025

Dir Wehrwein Files To Sell 5,033 Of AtriCure Inc [ATRC] - TradingView

Nov 24, 2025

Nov 22, 2025